BMJ open

Low-dose naltrexone's effects in long COVID: a combined review and analysis

Updated

Abstract

The effect of low-dose naltrexone (LDN) on long covid symptoms is currently unclear.

  • Long covid is a debilitating chronic condition affecting many individuals.
  • Low-dose naltrexone (LDN) is being investigated for its potential to alleviate symptoms of long covid.
  • The effectiveness of LDN for treating long covid symptoms remains uncertain based on current evidence.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No competing interests reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free